JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M006347200 on August 25, 2000

J. Biol. Chem., Vol. 275, Issue 47, 37271-37277, November 24, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/47/37271    most recent
M006347200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujiwara, C.
Right arrow Articles by Osumi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujiwara, C.
Right arrow Articles by Osumi, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Catalase-less Peroxisomes

IMPLICATION IN THE MILDER FORMS OF PEROXISOME BIOGENESIS DISORDER*

Chiharu FujiwaraDagger §, Atsushi Imamura, Noriyo HashiguchiDagger , Nobuyuki Shimozawa, Yasuyuki Suzuki, Naomi Kondo, Tsuneo Imanaka||, Toshiro TsukamotoDagger , and Takashi OsumiDagger **

From the Dagger  Department of Life Science, Faculty of Science, Himeji Institute of Technology, 3-2-1 Koto, Kamigori, Hyogo 678-1297, the  Department of Pediatrics, Gifu University School of Medicine, 40 Tsukasa-Machi, Gifu 500-8076, and the || Department of Biological Chemistry, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan

Received for publication, July 18, 2000, and in revised form, August 18, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We established a Chinese hamster ovary cell line having a temperature-sensitive phenotype in peroxisome biogenesis. This mutant (65TS) was produced by transforming a PEX2-defective mutant, Z65, with a mutant PEX2 gene, PEX2E55K, derived from a patient with infantile Refsum disease, a milder form of peroxisome biogenesis disorder. In 65TS, catalase was found in the cytosol at a nonpermissive temperature (39 °C), but upon the shift to a permissive temperature (33 °C), catalase gradually localized to the structures containing a 70-kDa peroxisomal membrane protein, PMP70. In contrast to catalase, other matrix proteins containing typical peroxisome targeting signals, acyl-CoA oxidase and peroxisomal 3-ketoacyl-CoA thiolase, were co-localized with PMP70 in most cells, even at 39 °C. We found that these structures are partially functional peroxisomes and named them "catalase-less peroxisomes." Catalase-less peroxisomes were also observed in human fibroblasts from patients with milder forms of peroxisome biogenesis disorder, including the one from which the mutant PEX2 gene was derived. We suggest that these structures are the causes of the milder phenotypes of the patients. Temperature-dependent restoration of the peroxisomes in 65TS occurred even in the presence of cycloheximide, a protein synthesis inhibitor. Thus, we conclude that in 65TS, catalase-less peroxisomes are the direct precursors of peroxisomes.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Peroxisomes are present in a wide variety of eukaryotic cells, from yeast to human (1). Peroxisomes commonly contain catalase and at least one enzyme that generates hydrogen peroxide. The roles of mammalian peroxisomes include oxidative processes involving H2O2, beta -oxidation of fatty acids, and biosynthesis of plasmalogens.

More than 20 genes named PEX (2) have been shown to be involved in peroxisome assembly processes, based on the functional complementation of genetically peroxisome-deficient mutants of mammalian cells and yeasts (3). Peroxisomes have been thought to be formed by the division of preexisting peroxisomes following the import of newly synthesized peroxisomal proteins (4), but recent observations suggest that endoplasmic reticulum may be involved in the peroxisomal membrane biogenesis at least in certain yeast species (5, 6; for review, see Ref. 7). Thus, questions are again being raised about the intracellular origin of peroxisomes.

Peroxisome biogenesis disorders (PBDs)1 are caused by abnormalities in the assembly processes of peroxisomes. In many PEX mutant cells, including the fibroblasts from PBD patients, abnormal membrane structures called peroxisomal ghosts are observed (8, 9). These structures contain a 70-kDa peroxisomal membrane protein (PMP70) but lack the peroxisomal matrix proteins. PBDs are genetically classified into at least 12 complementation groups (CGs) (10), and each CG contains various clinical phenotypes, e.g. Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease (IRD). ZS represents the severest form of PBD, NALD is the next severest, and IRD is the mildest (11). These diseases differ markedly in clinical features, such as age of death and severity of the neurological abnormalities.

In the fibroblasts of PBD patients with milder forms, temperature sensitivity was observed in peroxisome assembly, and heterozygous mutations (E55K/R119Stop) were identified in the PEX2 genes of an IRD fibroblast line of CG-F (12). Temperature-sensitive (TS) mutations were further identified in PEX1 (13) as well as PEX13 (14). The TS mutant cells seem to be useful tools for investigating the mechanisms of peroxisome biogenesis, because the peroxisome recovery process can be turned on simply by shifting the culture temperature. Accordingly, we established a stable Chinese hamster ovary (CHO) cell transformant with PEX2E55K (65TS) on the background of a PEX2-defective mutant, Z65 (15). In 65TS, peroxisomes formed temperature-dependently. We now report that in 65TS the peroxisomal ghosts indeed are partially functional "catalase-less peroxisomes." Similar structures were also observed in the fibroblasts from several patients with milder forms of PBD, including the original IRD fibroblast line of CG-F. We suggest that catalase-less peroxisomes are the cause of the milder phenotypes of these patients. In addition, we present evidence that peroxisomes are formed from the catalase-less peroxisomes in 65TS upon temperature shift-down.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Establishment of the TS Model Cells-- The human PEX2E55K cDNA subcloned in the expression vector pUcD2SRalpha MCS (16) was transfected to a PEX2-deficient CHO cell mutant, Z65, by the calcium phosphate method. Stable clones were selected by limiting dilution, by culturing the transfectants for 6 days in the presence of 400 µg/ml G418. One of the stable transformants revealed a punctate distribution of catalase after 72 h of incubation at 30 °C but no catalase-positive granules at 37 °C, like Z65. We named this clone 65TS. To visualize the peroxisomes in living 65TS cells, we produced a transformant stably expressing green fluorescent protein (GFP)-SKL. This fusion protein has the carboxyl-terminal 25 residues of rat acyl-CoA oxidase (AOX) containing the Ser-Lys-Leu-COOH tripeptide (a typical peroxisome targeting signal (PTS)-1) motif (17, 18) at the carboxyl terminus of GFP(105). GFP(105) is a variant green fluorescent protein having much improved fluorescence at higher temperatures (19). An expression vector of GFP-SKL, pGFP-SKL, and pMiwhph, a vector carrying a marker gene conferring hygromycin resistance, were co-transfected to 65TS by the calcium phosphate method. Selection was carried out by limiting dilution, by culturing the transfectants for 9 days in the presence of 400 units/ml hygromycin B, and then by culturing for 5 days with both G418 and hygromycin B. A stable clone with a punctate distribution of GFP at 30 °C was isolated and named 65TS-TSKL.

Cell Culture-- Cells were cultured in Ham's F-12 medium supplemented with 10% fetal calf serum. The fibroblasts from PBD patients were maintained at 37 °C in 5% CO2, and TS CHO mutant cells were maintained at 39 °C in 5% CO2. For the analysis of temperature-dependent peroxisome restoration, temperature pairs of 37/30 °C and 39/33 °C were used for human fibroblasts and CHO cells, respectively. Higher temperatures were used for the CHO-derived cells, because they grew much faster at 33 °C than 30 °C and exhibited clearer TS phenotypes at 39 °C than at 37 °C.

Immunofluorescence Studies-- Peroxisomes of CHO cells and human fibroblasts were visualized by indirect immunofluorescence staining, as described (20). The first antibodies used were rabbit antibodies to rat catalase (from Dr. N. Usuda), rat AOX, rat peroxisomal 3-ketoacyl-CoA thiolase (PT), and human catalase (each from Dr. T. Hashimoto), and rat PMP70 or guinea pig antibodies to rat PMP70 and catalase. The anti-PMP70 antibodies were prepared using the carboxyl-terminal 15-residue peptide of the protein as an antigen (21). The antigen-antibody complexes were detected with fluorescein isothiocyanate- or Cy3-labeled goat antibody to rabbit IgG or Cy3-labeled donkey antibody to guinea pig IgG.

Radiolabeling of Cells-- Cells were cultured in Ham's F-12 medium supplemented with 10% fetal calf serum for 2 days at selected temperatures. The medium was changed to Dulbecco's modified Eagle's medium containing proline but lacking cysteine and methionine and supplemented with dialyzed fetal calf serum at 10%. After incubation for 24 h at each temperature with 100 µCi/ml [35S]methionine/[35S]cysteine mixture (PerkinElmer Life Sciences), cells were lysed and subjected to immunoprecipitation with specific rabbit antibodies to rat AOX, catalase, and PMP70. Immunocomplexes were recovered with fixed Staphylococcus aureus cells (Zysorbin, Zymed Laboratories Inc.) and analyzed by SDS-polyacrylamide gel electrophoresis followed by autoradiography, as described (22). For the experiment on the effect of cycloheximide, the drug was added at varying concentrations to the medium 1 h before the addition of radioactive amino acids, and the radioisotope was allowed to be incorporated for 24 h at 33 °C.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Isolation and Characterization of the TS CHO Mutant-- We previously showed that an IRD patient with CG-F PBD carried heterozygous mutations in the PEX2 gene, E55K and R119Stop (12) (Fig. 1A), and the former was responsible for the TS phenotype of the patient's cells in peroxisome assembly. We isolated a temperature-sensitive CHO mutant, 65TS, by introducing the E55K mutant PEX2 gene into the PEX2-defective CHO mutant, Z65 (15). Z65 itself exhibited a punctate distribution of catalase at neither 33 °C (Fig. 1B, a) nor 39 °C (data not shown), although PMP70 exhibited a punctate staining pattern, representing the ghosts (Fig. 1B, b). In 65TS, catalase was found in the cytosol at 39 °C (Fig. 1B, c), whereas PMP70 had a particulate distribution (Fig. 1B, d). When 65TS was incubated at 33 °C for 48 h, however, catalase was co-localized with PMP70 in almost all the cells (Fig. 1B, e and f). We pursued the time course of peroxisome recovery in 65TS (Fig. 2). After 3 h of incubation at 33 °C, we observed some cells containing a few punctates of catalase. After 6 h, we could identify in many cells catalase-positive granules that were also positive for PMP70 (data not shown). Most cells contained catalase-positive granules after 24 h of incubation at 33 °C, and virtually all cells had peroxisomes by 48 h. Thus, it took at least 3 to 6 h for the recovery of peroxisomes in 65TS, and the process was completed within 48 h.


View larger version (81K):
[in this window]
[in a new window]
 
Fig. 1.   Establishment of TS CHO Mutant. A, diagram of Pex2p primary structure and mutations found in the patients. Patient F-01 was homozygous for the R119Stop mutation (42), whereas F-05 was a heterozygote of E55K and R119Stop mutations (12). Stippled boxes, hydrophobic regions; shadowed box, Ring finger motif (15, 43). B, immunofluorescent staining of catalase (a, c, and e) and PMP70 (b, d, and f) of mutant CHO cells. a and b, Z65; c-f, 65TS. Cells were cultured at 33 °C (a and b), 39 °C (c and d), and first at 39 °C then at 33 °C for 48 h (e and f). Each pair of pictures side by side represents the same microscopic fields. The exposure time was automatically adjusted according to the brightness of the objects. Hence, these pictures do not necessarily accurately reflect the relative fluorescence intensities. Bar, 20 µm.


View larger version (79K):
[in this window]
[in a new window]
 
Fig. 2.   Time course of peroxisome recovery in 65TS. The cells were first cultured at 39 °C and then kept for the period indicated at 33 °C. Although only the immunostaining patterns for catalase are shown, PMP70 staining was also carried out to confirm the co-localization. Bar, 20 µm.

With respect to the peroxisome assembly, 65TS shuttled between the phenotypes similar to the wild-type CHO and Z65, depending on the temperatures. Fibroblasts from a TS patient belonging to CG-F (F-05) lack the peroxisomes, like the fibroblasts from ZS patients at 37 °C, but when incubated at 30 °C, the F-05 fibroblasts regain the peroxisomes to the same level as those of the normal fibroblasts (12). Thus, the phenotypes of 65TS seemed similar to those of the fibroblasts from the TS patient and would be useful for studying the mechanism of peroxisome biogenesis and molecular defects of TS PBDs.

Proteins Carrying Typical PTSs Are Localized to Peroxisome-like Structures at the Nonpermissive Temperature-- Using GFP-SKL carrying a typical PTS-1 at the carboxyl end, we tried to visualize the peroxisomes in living 65TS cells. Interestingly, the stable transformant expressing GFP-SKL, named 65TS-TSKL, revealed a punctate GFP distribution consistent with that of PMP70 at 39 °C (Fig. 3, a and b) as well as at 33 °C (Fig. 3, c and d). This was in contrast to the cytosolic distribution of catalase at 39 °C (Fig. 3, e and f). Catalase exhibited punctate staining superimposable with the GFP-SKL distribution in 65TS-TSKL at 33 °C (Fig. 3, g and h). Even at the permissive temperature, however, the punctate distribution of catalase and expression of GFP-SKL were complementary to each other, i.e. catalase-positive particles were only observed in the cells weakly expressing GFP-SKL (see Fig. 3 legend). On the other hand, we observed that AOX and PT, having a typical PTS-1 and PTS-2, respectively, were colocalized with GFP-SKL to particulate structures at 39 °C (data not shown). Catalase has a variant PTS-1, KANL, at the carboxyl terminus. Thus, we reasoned that the proteins carrying typical PTSs would be translocated to the peroxisome-like structures more easily than catalase. Typical PTS proteins but not catalase would be translocated at 39 °C, and the former would be more efficiently imported to peroxisomes than the latter at 33 °C.


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 3.   GFP-SKL is accumulated in peroxisome-like structures in the TS cells even at 39 °C. Cells of the stable transformant of 65TS with GFP-SKL, 65tsTSKL, were cultured at 39 °C (a, b, e, and f) or 33 °C (c, d, g, and h). The green fluorescence of GFP-SKL (a, c, e, and g) was observed on the same field as that for the immunostaining of PMP70 (b and d) and catalase (f and h), with the Cy3-labeled second antibody. Pairs of pictures of the same fields are presented side by side. Bar, 10 µm. Note that all GFP-SKL transformant cells did not express GFP-SKL efficiently, as particularly emphasized in e and g. We usually observe such variable expression of stably integrated ectopic genes among the cells derived from a single clone, even when the cells are maintained in selection media. This phenomenon is probably related to the stochastic nature of the actions of gene enhancers to increase the probability but not the level of gene expression (44). Thus, a substantial number of the cells in a given population would not express the gene under consideration, by chance.

Catalase-less Peroxisomes in 65TS Cells at the Nonpermissive Temperature----- We next examined the localization of the peroxisomal matrix proteins in the original 65TS cells instead of 65TS-TSKL (Fig. 4A). When 65TS cells were stained with anti-AOX or anti-PT antibody, punctate staining overlapping with that of PMP70 was observed, even at 39 °C. In a parallel experiment, we confirmed that catalase was diffusely distributed in the cytosol at this temperature (data not shown). Thus, the proteins having typical PTSs were indeed selectively translocated to peroxisome-like structures at the nonpermissive temperature. Catalase, on the other hand, was hardly imported to these structures under the same conditions. This seems rather surprising, because catalase has been used as a representative marker of peroxisomes.


View larger version (108K):
[in this window]
[in a new window]
 
Fig. 4.   Translocation of AOX and PT to peroxisome-like structures in 65TS at 39 °C. A, colocalization of AOX and PT with PMP70. 65TS cells were cultured at 39 °C and immunostained for AOX (a), PMP70 (b and d), and PT (c). Pairs of pictures of the same fields are presented side by side. Bar, 10 µm. B, radiolabeling of AOX. Wild-type CHO (lanes 1 and 4), Z65 (lanes 2 and 5), and 65TS (lanes 3 and 6) were radiolabeled with [35S]methionine/cysteine for 24 h at 39 °C (lanes 1-3) or 33 °C (lanes 4-6). Radiolabeled AOX was immunoprecipitated, separated by SDS-polyacrylamide gel electrophoresis, and detected by autoradiography. The full-length polypeptide A and processing product B are indicated by arrowheads. The smaller processing product C was hardly detectable. A nonspecific faint band usually appears at the same position as that of band B (15).

We examined whether these peroxisome-like structures had normal biochemical functions of peroxisomes, based on several criteria. We first inspected whether AOX was correctly processed in these structures by a radiolabeling experiment, as described (22). For 65TS incubated at 33 °C, processing of AOX (proteolytic conversion of the component A to components B and C (18), although component C was hardly detected under these conditions) was observed to the same extent as in the wild-type CHO (Fig. 4B). Comparable amounts of the enzyme (the sum of components A and B) were recovered from 65TS and the wild-type CHO; these amounts were significantly larger than that from Z65, reflecting the stabilization of the enzyme by segregation into peroxisomes. It was indeed shown (15) that AOX is highly unstable in Z65 and stabilized upon complementation by the normal PEX2 gene. These results indicate that normal peroxisomes were formed in 65TS by shifting the temperature to 33 °C. Even at 39 °C, the total amounts of components A and B were comparable in 65TS and the wild-type CHO and were much larger than in Z65. This suggested that, even at 39 °C, AOX was segregated into peroxisomes or peroxisome-like structures in 65TS to an extent close to that in the wild-type CHO. A less efficient but considerable level of processing was observed in 65TS at 39 °C (Fig. 4B, lane 3), suggesting a partial functionality of the processing system at this temperature. The poorer processing would not affect the enzymatic function of AOX, because it is known that the unprocessed recombinant AOX expressed in Escherichia coli is fully active (23).

To further evaluate the metabolic functions of these peroxisome-like structures, the beta -oxidation capacity of very long chain fatty acid (VLCFA) and peroxisomal dihydroxyacetone phosphate acyltransferase (DHAP-AT) activity were measured (Table I). 65TS incubated at both 30 and 37 °C exhibited significant VLCFA beta -oxidation and peroxisomal DHAP-AT activities, which were comparable with those of the wild-type CHO. Note that these experiments were done at the 30/37 °C temperature pair, because the experimental conditions had been established at these temperatures. Thus, the biochemical activities of the peroxisome-like structures observed in 65TS at higher temperatures were normal with respect to these two parameters. Hence, we concluded that these structures indeed were nearly functional peroxisomes, though their functions seemed partial, because they lacked catalase and had much lower processing activity of AOX. We named the structures catalase-less peroxisomes.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Capacity of VLCFA beta -oxidation and peroxisomal DHAP-AT activity
Cells were cultured for 8 days at 37 °C or 30 °C and then measured for the enzyme activities at 37 °C. The beta -oxidation activities of palmitic (C16) and lignoceric (C24) acids were measured, and the VLCFA beta -oxidation capacity was represented by the ratio of the activities against C24 and C16 fatty acids (45). The activity of peroxisomal DHAP-AT was measured as described (46) and expressed as nmol/2 h/mg protein. Two independent experiments gave similar relativity among the activities of different cell lines and at different temperatures, although the absolute values varied. Result of a single experiment is shown.

Catalase-less Peroxisomes in Human PBD Fibroblasts-- Catalase-less peroxisomes were also found in the IRD fibroblast line of CG-F that originally carried the PEX2E55K mutation (Fig. 5). Although catalase exhibited only diffuse cytosolic staining, both AOX and PT did exhibit a punctate distribution in many cells at 37 °C. The punctate pattern was more prominent and found in a higher percentage of cells (more than 70% of the total) with anti-PT antibody than with anti-AOX antibody, indicating an efficient translocation of PT in this IRD cell line. AOX, PT, and catalase were all cytosolic in the ZS cells of CG-F (F-01) (data not shown). It should be noted that the VLCFA beta -oxidation and DHAP-AT activities of the same CG-F TS human fibroblasts as used in this study (F-05) were considerably higher than those of the CG-F ZS fibroblasts, even at 37 °C (24). Thus, the milder phenotypes of this IRD patient are likely to have resulted from these catalase-less peroxisomes, having partial biochemical functions at 37 °C. It should be pointed out, however, that the functions of the catalase-less peroxisomes of human fibroblasts were significantly reduced compared with those of 65TS, with respect to these biochemical parameters.


View larger version (115K):
[in this window]
[in a new window]
 
Fig. 5.   Catalase-less peroxisomes of the fibroblasts F-05. Cells were cultured at 37 °C and immunostained for catalase (a), AOX (c), PT (e), and PMP70 (b, d, and f). Pictures of the same fields are presented side by side. Bar, 30 µm.

Catalase has usually been used as the definitive marker to discriminate normal peroxisomes from nonfunctional peroxisomal ghosts. The presence of catalase-less peroxisomes in an IRD patient of CG-F (F-05) raised the question whether patients with milder forms of PBD generally have hitherto overlooked similar structures. Accordingly, we examined this possibility with the fibroblasts from an NALD patient of CG-C (C-11)2 and an NALD and IRD patient of CG-E (E-13 and E-24, respectively; see Ref. 13). The responsible genes of CG-C and CG-E are PEX6 (16, 25, 26) and PEX1 (27-29), respectively, both coding for the members of the AAA-ATPase family. Interaction between these two peroxins was shown (30-32), and hence it would seem reasonable that a defect in either of them would result in similar phenotypes. In addition, a TS mutation (G843D) has been identified in the PEX1 gene of patient E-24 (13). When these fibroblasts were cultured at 37 °C, catalase was found in the cytosol, without a punctate pattern of distribution (Fig. 6). On the other hand, AOX and PT exhibited punctate staining in around 80% of cells (Fig. 6), although the signals were weaker, and the number of particles in each cell was smaller than in normal cells (data not shown). These particles were mostly superimposable with those of PMP70 and hence regarded as peroxisome-related structures, although some particles seemed to be irregular protein aggregates not overlapping with PMP70 signals. Heavy abnormal aggregations of AOX and PT were observed in a considerable number of cells, especially for C-11 and E-13 (data not shown). All cells contained many PMP70-positive particles. A considerable number of these particles were negative or below the detection limit for the staining of AOX or PT. Thus, the import of AOX and PT in these mutant cells seemed less efficient than that in normal cells. We observed no such particulate staining of AOX in ZS cells of the same CGs, although weak particulate signals of PT were found in a small number of cells (data not shown). Hence, we conclude that the cells of milder PBD phenotypes contain catalase-less peroxisomes for at least CGs C, E, and F, albeit at lower levels of matrix protein accumulation in these structures.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 6.   Catalase-less peroxisomes of the CG-C and CG-E fibroblasts. NALD fibroblasts of CG-C (C-11; a-f) and CG-E (E-13; g-l) and IRD fibroblasts of CG-E (E-24; m-r) were cultured at 37 °C and immunostained for catalase (a, g, and m), AOX (c, i, and o), PT (e, k, and q), and PMP70 (b, d, f, h, j, l, n, p, and r). Pairs of pictures presented side by side in the two rows on the left, middle, and right represent the same fields. Bar, 40 µm.

Peroxisomes Are Formed from the Catalase-less Peroxisomes in 65TS Cells-- In 65TS cells, peroxisomes were formed temperature-dependently. To examine whether peroxisomes were restored from the preexisting catalase-less peroxisomes by the import of catalase from the cytosol, we investigated whether the recovery process was inhibited by cycloheximide, a protein synthesis inhibitor. 65TS cells cultured at 39 °C were further cultured for 24 h at 33 °C in the presence or absence of 10 µg/ml cycloheximide. Immunostaining of catalase showed that the enzyme was colocalized with PMP70 even in the presence of the drug (Fig. 7A, c and d), although the PMP70-containing structures seemed to be large in size and irregular in shape as compared with those of the cells cultured without the drug (Fig. 7A, a and b). By radiolabeling the cells, we confirmed that this concentration of cycloheximide completely inhibited the synthesis of catalase and PMP70 (Fig. 7, B and C). Total protein synthesis also virtually ceased at this concentration of the drug (Fig. 7D), and the incorporation of radioactivity into trichloroacetic acid-insoluble materials decreased by 97% under these conditions (data not shown).


View larger version (79K):
[in this window]
[in a new window]
 
Fig. 7.   TS restoration of peroxisomes is not blocked by cycloheximide. A, translocation of catalase to catalase-less peroxisomes. 65TS cells were cultured first at 39 °C and then for 24 h in the absence (a and b) or presence (c and d) of 10 µg/ml cycloheximide at 33 °C. Immunostaining was performed for catalase (a and c) and PMP70 (b and d). Pictures of the same fields are presented side by side. Bar, 10 µm. B, C, and D, radiolabeling of PMP70, catalase, and total proteins, respectively. 65TS cells were incubated at 33 °C in the presence of [35S]methionine/[35S]cysteine and cycloheximide at the concentrations indicated (in µg/ml). Cells were lysed with an equal amount of lysis solution, and equal amounts of lysates were subjected to immunoprecipitation (B and C) or analyzed directly by SDS-polyacrylamide gel electrophoresis (D).

These results suggest that the cytosolically distributed catalase became colocalized with the pre-accumulated PMP70 upon temperature shift, without requiring de novo protein synthesis. This also means that pre-accumulated mutant Pex2p is converted from a less active to an active form upon temperature shift, which in turn supports the translocation of catalase. Hence, we conclude that peroxisomes are derived from the catalase-less peroxisomes in 65TS. These results well conform to the notion that peroxisomes are formed from the ghosts by functional complementation of the peroxisome-deficient mutant cells (33). In addition, these results support the hypothesis that peroxisomes can develop by incorporating the newly synthesized peroxisomal proteins from the cytosol.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The present results indicate that transfer of the PEX2E55K gene into the PEX2-defective CHO mutant, Z65, transmitted the TS phenotype observed in the F-05 IRD fibroblasts. In the resulting CHO line, 65TS, catalase was found in the cytosol at 39 °C, but its distribution became peroxisomal upon shift-down to 33 °C. On the other hand, AOX and PT carrying a typical PTS-1 and PTS-2, respectively, exhibited a peroxisomal distribution in many cells, even at 39 °C. Although catalase seems to be translocated by the PTS-1 pathway, its KANL peptide sequence at the carboxyl terminus deviates from the consensus (34). Therefore, the complex of catalase and Pex5p, the PTS-1 receptor, is possibly formed with lower efficiency than complexes of typical PTS-1 proteins. This would make the steady state concentration of catalase-Pex5p too low to be captured by the peroxisomal import machinery containing the TS Pex2p, at the nonpermissive temperature. The effect of poorer recognition by the receptor is accentuated when catalase must compete with an excess amount of a typical PTS-1 protein (Fig. 3, g and h). In this situation, catalase is not translocated to peroxisomes to a significant extent even at 33 °C. Proteins carrying typical PTSs, however, form high steady state concentrations of the complexes with the receptors, high enough to be recognized even by the less active import machinery at the nonpermissive temperature.

The restoration of catalase import at the permissive temperature clearly depends on the transition of the mutant Pex2p from the less active (or inactive) state to the (more) active state, because the process was not inhibited by cycloheximide. The mutant Pex2p would be integrated into the membrane of the catalase-less peroxisomes normally even at the nonpermissive temperature, thus supporting the import of typical PTS proteins and, upon temperature shift-down, the import of catalase. It is reasonable to suspect that the mutant Pex2p is in an equilibrium between the two states at any temperature. Thus, at 39 °C, the total activity of the import machinery involving the mutant Pex2p would be insufficient to support the translocation of catalase but nearly sufficient to take up typical PTS proteins, whereas the activity would reach a level high enough to allow the catalase import at 33 °C. To verify this notion, we expressed the PEX2E55K gene at a lower level by putting the gene under the control of the basal promoter of the herpes simplex virus thymidine kinase gene. This resulted in incomplete import of AOX and PT at 39 °C and poor catalase import even at 33 °C (data not shown). Thus, the import efficiencies of individual peroxisomal matrix proteins depend on a delicate balance between the intrinsic intensities of the individual import signals and the net activity of the peroxisomal import machinery.

The peroxisome-like structures observed in 65TS cells at 39 °C, which contain AOX and PT but not catalase, indeed are nearly functional catalase-less peroxisomes (Table I and Fig. 4B). AOX was equally stable at 39 °C as in the wild-type CHO cells, probably reflecting the effective segregation into the peroxisomal lumen. The processing of AOX, however, was less efficient, possibly because of poorer assembly of the processing system. Catalase-less peroxisomes were also observed in the fibroblasts of PBD patients with milder phenotypes, belonging to three CGs: C, E, and F. The CG-F patient was the original carrier of the PEX2E55K mutant gene. In these cells, AOX and PT exhibited punctate patterns of distribution overlapping with that of PMP70 at 37 °C, although the staining intensities were weaker than those in 65TS. In the CG-F cells, the VLCFA oxidation and DHAP-AT activities were higher than those of ZS cells of the same CG, although much lower than the wild-type activities (24, 35). Thus, the patient fibroblasts of CG-F and the 65TS model CHO cells had similar TS phenotypes, but the functional defect at the nonpermissive temperature was much more prominent in the former. This was probably due to the weaker expression of the endogenous PEX2 gene in the human fibroblasts than of the ectopic PEX2 gene under the control of the viral expression system, which was carried by 65TS. The present observations suggest that the partially functional catalase-less peroxisomes would support the milder phenotypes of NALD and IRD patients, at least in the cases studied. Evaluation of peroxisomes of PBD patients based on immunofluorescent microscopy should be done not only for catalase but also for typical PTS proteins such as beta -oxidation enzymes.

Import of catalase to the catalase-less peroxisomes at the permissive temperature was not inhibited by cycloheximide, a protein synthesis inhibitor. The most feasible interpretation of these results would be that the catalase pre-accumulated in the cytosol directly enters the preexisting catalase-less peroxisomes. The involvement of a vesicle fusion process in peroxisome biogenesis was proposed, based on the results of biochemical studies (36). It was also suggested that catalase import occurs only to immature peroxisomes (or precursor vesicles), not mature peroxisomes. Our results would be compatible with this model if we suppose the involvement of recycling membrane vesicles in the translocation of pre-accumulated catalase to the catalase-less peroxisomes.

The present results are consistent with the result for the PEX5 mutant CHO cells (33) that the restoration of peroxisomes by the microinjection of Pex5p can occur in the presence of cycloheximide and hence involves the translocation of the cytosolically accumulated PTS proteins into the peroxisomal ghosts. Catalase-less peroxisomes as well as peroxisomal ghosts are the structures that form on the blockade of the normal course of peroxisome biogenesis because of a deficiency of one of the essential PEX gene products. Thus, these structures reflect the processes of peroxisome biogenesis, even if they themselves do not represent the biogenesis intermediates. They are ready to accept the PTS proteins if the correct PEX gene products are supplied. The shapes and biochemical compositions, however, may differ depending on the defective gene as well as the severity of deficiency. The recovery processes also probably differ depending on the defective genes. Moreover, net formation of the peroxisomal membrane from a certain membrane seems essential in the mutants defective in one of the three PEX genes, PEX3, PEX16, and PEX19, because these mutants lack peroxisomal ghosts but nevertheless are complemented for peroxisome biogenesis by the transfer of respective genes (10, 37-41). Clues to the biochemical mechanism of peroxisome biogenesis would be obtained by characterizing the processes of genetic complementation of the respective PEX mutants.

    ACKNOWLEDGEMENT

We thank Dr. F. Tokunaga for the help on protein radiolabeling experiments.

    FOOTNOTES

* This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Kaken Pharmaceutical Co., 14 Shinomiya Minamikawara-cho, Yamashina-ku, Kyoto 607-8042, Japan.

** To whom correspondence should be addressed. Tel.: 81-791-58-0192; Fax:81-791-58-0193; E-mail: osumi@sci.himeji-tech.ac.jp.

Published, JBC Papers in Press, August 25, 2000, DOI 10.1074/jbc.M006347200

2 A. Imamura, N. Shimozawa, Y. Suzuki, and N. Kondo, unpublished result on the assignment of patient.

    ABBREVIATIONS

The abbreviations used are: PBD, peroxisome biogenesis disorder; PMP70, 70-kDa peroxisomal membrane protein; CG, complementation group; ZS, Zellweger syndrome; NALD, neonatal adrenoleukodystrophy; IRD, infantile Refsum disease; TS, temperature-sensitive; CHO, Chinese hamster ovary; GFP, green fluorescent protein; AOX, acyl-CoA oxidase; PTS, peroxisome targeting signal; PT, peroxisomal 3-ketoacyl-CoA thiolase; VLCFA, very long chain fatty acid; DHAP-AT, peroxisomal dihydroxyacetone phosphate acyltransferase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Lazarow, P. B., and Fujiki, Y. (1985) Annu. Rev. Cell Biol. 1, 489-530
2. Distel, B., Erdmann, R., Gould, S. J., Blobel, G., Crane, D. I., Cregg, J. M., Dodt, G., Fujiki, Y., Goodman, J. M., Just, W. W., Kiel, J. A., Kunau, W. H., Lazarow, P. B., Mannaerts, G. P., Moser, H. W., Osumi, T., Rachubinski, R. A., Roscher, A., Subramani, S., Tabak, H. F., Tsukamoto, T., Valle, D., van der Klei, I., van Veldhoven, P., and Veenhuis, M. (1996) J. Cell Biol. 135, 1-3
3. Tabak, H. F., Braakman, I., and Distel, B. (1999) Trends Cell Biol. 9, 447-453
4. Lazarow, P. B., Robbi, M., Fujiki, Y., and Wong, L. (1982) Ann. N. Y. Acad. Sci. 386, 285-300
5. Elgersma, Y., Kwast, L., van den Berg, M., Snyder, W. B., Distel, B., Subramani, S., and Tabak, H. F. (1997) EMBO J. 16, 7326-7341
6. Titorenko, V. I., and Rachubinski, R. A. (1998) Mol. Cell. Biol. 18, 2789-2803
7. Kunau, W. H., and Erdmann, R. (1998) Curr. Biol. 8, R299-R302
8. Santos, M. J., Imanaka, T., Shio, H., Small, G. M., and Lazarow, P. B. (1988) Science 239, 1536-1538
9. Santos, M. J., Imanaka, T., Shio, H., and Lazarow, P. B. (1988) J. Biol. Chem. 263, 10502-10509
10. Shimozawa, N., Suzuki, Y., Zhang, Z., Imamura, A., Kondo, N., Kinoshita, N., Fujiki, Y., Tsukamoto, T., Osumi, T., Imanaka, T., Orii, T., Beemer, F., Mooijer, P., Dekker, C., and Wanders, R. J. (1998) Am. J. Hum. Genet. 63, 1898-1903
11. Lazarow, P. B., and Moser, H. W. (1995) in The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R. , Beaudet, A. L. , Sly, W. S. , and Valle, D., eds), 7th Ed. , pp. 2287-2324, McGraw-Hill Inc., New York
12. Imamura, A., Tsukamoto, T., Shimozawa, N., Suzuki, Y., Zhang, Z., Imanaka, T., Fujiki, Y., Orii, T., Kondo, N., and Osumi, T. (1998) Am. J. Hum. Genet. 62, 1539-1543
13. Imamura, A., Tamura, S., Shimozawa, N., Suzuki, Y., Zhang, Z., Tsukamoto, T., Orii, T., Kondo, N., Osumi, T., and Fujiki, Y. (1998) Hum. Mol. Genet. 7, 2089-2094
14. Shimozawa, N., Suzuki, Y., Zhang, Z., Imamura, A., Toyama, R., Mukai, S., Fujiki, Y., Tsukamoto, T., Osumi, T., Orii, T., Wanders, R. J., and Kondo, N. (1999) Hum. Mol. Genet. 8, 1077-1083
15. Tsukamoto, T., Miura, S., and Fujiki, Y. (1991) Nature 350, 77-81
16. Tsukamoto, T., Miura, S., Nakai, T., Yokota, S., Shimozawa, N., Suzuki, Y., Orii, T., Fujiki, Y., Sakai, F., Bogaki, A., Yasumo, H., and Osumi, T. (1995) Nat. Genet. 11, 395-401
17. Miyazawa, S., Osumi, T., Hashimoto, T., Ohno, K., Miura, S., and Fujiki, Y. (1989) Mol. Cell. Biol. 9, 83-91
18. Miyazawa, S., Hayashi, H., Hijikata, M., Ishii, N., Furuta, S., Kagamiyama, H., Osumi, T., and Hashimoto, T. (1987) J. Biol. Chem. 262, 8131-8137
19. Yamasaki, M., Hashiguchi, N., Tsukamoto, T., and Osumi, T. (1998) Bioimages 6, 1-7
20. Osumi, T., Tsukamoto, T., Hata, S., Yokota, S., Miura, S., Fujiki, Y., Hijikata, M., Miyazawa, S., and Hashimoto, T. (1991) Biochem. Biophys. Res. Commun. 181, 947-954
21. Imanaka, T., Shiina, Y., Takano, T., Hashimoto, T., and Osumi, T. (1996) J. Biol. Chem. 271, 3706-3713
22. Tsukamoto, T., Yokota, S., and Fujiki, Y. (1990) J. Cell Biol. 110, 651-660
23. Setoyama, C., Tamaoki, H., Nishina, Y., Shiga, K., and Miura, R. (1995) Biochem. Biophys. Res. Commun. 217, 482-487
24. Imamura, A., Shimozawa, N., Suzuki, Y., Zhang, Z., Tsukamoto, T., Fujiki, Y., Orii, T., Osumi, T., and Kondo, N. (2000) Brain Dev. 22, 8-12
25. Fukuda, S., Shimozawa, N., Suzuki, Y., Zhang, Z., Tomatsu, S., Tsukamoto, T., Hashiguchi, N., Osumi, T., Masuno, M., Imaizumi, K., Kuroki, Y., Fujiki, Y., Orii, T., and Kondo, N. (1996) Am. J. Hum. Genet. 59, 1210-1220
26. Yahraus, T., Braverman, N., Dodt, G., Kalish, J. E., Morrell, J. C., Moser, H. W., Valle, D., and Gould, S. J. (1996) EMBO J. 15, 2914-2923
27. Portsteffen, H., Beyer, A., Becker, E., Epplen, C., Pawlak, A., Kunau, W. H., and Dodt, G. (1997) Nat. Genet. 17, 449-452
28. Reuber, B. E., Germain-Lee, E., Collins, C. S., Morrell, J. C., Ameritunga, R., Moser, H. W., Valle, D., and Gould, S. J. (1997) Nat. Genet. 17, 445-448
29. Tamura, S., Okumoto, K., Toyama, R., Shimozawa, N., Tsukamoto, T., Suzuki, Y., Osumi, T., Kondo, N., and Fujiki, Y. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 4350-4355
30. Tamura, S., Shimozawa, N., Suzuki, Y., Tsukamoto, T., Osumi, T., and Fujiki, Y. (1998) Biochem. Biophys. Res. Commun. 245, 883-886
31. Geisbrecht, B. V., Collins, C. S., Reuber, B. E., and Gould, S. J. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8630-8635
32. Faber, K. N., Heyman, J. A., and Subramani, S. (1998) Mol. Cell. Biol. 18, 936-943
33. Yamasaki, M., Hashiguchi, N., Fujiwara, C., Imanaka, T., Tsukamoto, T., and Osumi, T. (1999) J. Biol. Chem. 274, 35293-35296
34. Purdue, P. E., and Lazarow, P. B. (1996) J. Cell Biol. 134, 849-862
35. Shimozawa, N., Imamura, A., Zhang, Z., Suzuki, Y., Orii, T., Tsukamoto, T., Osumi, T., Fujiki, Y., Wanders, R. J., Besley, G., and Kondo, N. (1999) J. Med. Genet. 36, 779-781
36. Titorenko, V. I., Chan, H., and Rachubinski, R. A. (2000) J. Cell Biol. 148, 29-44
37. Hettema, E. H., Girzalsky, W., van den Berg, M., Erdmann, R., and Distel, B. (2000) EMBO J. 19, 223-233
38. Honsho, M., Tamura, S., Shimozawa, N., Suzuki, Y., Kondo, N., and Fujiki, Y. (1998) Am. J. Hum. Genet. 63, 1622-1630
39. South, S. T., and Gould, S. J. (1999) J. Cell Biol. 144, 255-266
40. Kinoshita, N., Ghaedi, K., Shimozawa, N., Wanders, R. J. A., Matsuzono, Y., Imanaka, T., Okumoto, K., Suzuki, Y., Kondo, N., and Fujiki, Y. (1998) J. Biol. Chem. 273, 24122-24130
41. Matsuzono, Y., Kinoshita, N., Tamura, S., Shimozawa, N., Hamasaki, M., Ghaedi, K., Wanders, R. J., Suzuki, Y., Kondo, N., and Fujiki, Y. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2116-2121
42. Shimozawa, N., Tsukamoto, T., Suzuki, Y., Orii, T., Shirayoshi, Y., Mori, T., and Fujiki, Y. (1992) Science 255, 1132-1134
43. Patarca, R., and Fletcher, M. A. (1992) FEBS Lett. 312, 1-2
44. Fiering, S., Whitelaw, E., and Martin, D. I. (2000) Bioessays 22, 381-387
45. Suzuki, Y., Shimozawa, N., Yajima, S., Yamaguchi, S., Orii, T., and Hashimoto, T. (1991) Biochem. Pharmacol. 41, 453-456
46. Shimozawa, N., Suzuki, Y., Orii, T., Yokota, S., and Hashimoto, T. (1988) Pediatr. Res. 24, 723-727


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J BiochemHome page
R. Ito, M. Morita, N. Takahashi, N. Shimozawa, N. Usuda, T. Imanaka, and M. Ito
Identification of Pex5pM, and Retarded Maturation of 3-Ketoacyl-CoA Thiolase and Acyl-CoA Oxidase in CHO Cells Expressing Mutant Pex5p Isoforms
J. Biochem., December 1, 2005; 138(6): 781 - 790.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. E. Legakis, J. I. Koepke, C. Jedeszko, F. Barlaskar, L. J. Terlecky, H. J. Edwards, P. A. Walton, and S. R. Terlecky
Peroxisome Senescence in Human Fibroblasts
Mol. Biol. Cell, December 1, 2002; 13(12): 4243 - 4255.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Guerra-Giraldez, L. Quijada, and C. E. Clayton
Compartmentation of enzymes in a microbody, the glycosome, is essential in Trypanosoma brucei
J. Cell Sci., January 7, 2002; 115(13): 2651 - 2658.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/47/37271    most recent
M006347200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujiwara, C.
Right arrow Articles by Osumi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujiwara, C.
Right arrow Articles by Osumi, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.